* Aspira Women's Health Inc AWH.OQ AWH.O is expected to show
a rise in quarterly revenue when it reports results on November
10.
* The Austin, Texas-based company is expected to report a
30.5% increase in revenue to $1.617 million from $1.24 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Aspira Women's Health
Inc is for a loss of 7 cents per share. For the same quarter
last year, the company reported a loss of 4 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Aspira Women's
Health Inc is $12, about 73.1% above its last closing price
of $3.23.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 30 2021 -0.06 -0.06 -0.06 Met 0
Mar. 31 2021 -0.23 -0.17 -0.05 Beat 71.2
Dec. 31 2020 -0.04 -0.58 Missed -1,350
Sep. 30 2020 -0.04 -0.04 -0.04 Met 0
-0.04
-0.04
This summary was machine generated November 8 at 13:40 GMT. All
figures in US dollars unless otherwise stated